Navigation Links
Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018
Date:11/9/2009

WALTHAM, Mass., Nov. 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies -- which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb -- were the highest-selling drug class in breast cancer treatment. Continued uptake of Herceptin and Tykerb/Tyverb and the expected launches of three new therapies will drive sales of HER2-targeting agents to grow by 3.3 percent per year from 2008 to 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Breast Cancer finds that significant declines in sales in the hormonal therapy and chemotherapy segments of the market will be offset by a 1.2 percent annual increase in breast cancer incidence in the world's major markets and by the launch and uptake of premium-priced agents. Emerging HER2-targeting therapies that are expected to launch by 2018 include Roche/Chugai's Omnitarg, Roche's T-DM1 and Wyeth's HKI-272.

The report also finds that sales of Roche/Chugai's Avastin for breast cancer will increase by four percent from 2008 to 2018, largely owing to greater uptake by patients with metastatic disease.

"Since its approval, Avastin has garnered substantial patient share in metastatic breast cancer, particularly in the metastatic triple-negative and metastatic HR-refractory treatment settings, where there is a significant need for effective therapeutic options," said Decision Resources Analyst Niamh Murphy, Ph.D. "However, many of the physicians we interviewed, particularly in Europe, are not very enthusiastic about Avastin for breast cancer because they consider its cost-benefit profile suboptimal."

According to the report, experts are enthusiastic about the launch and uptake of a novel class of breast cancer
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Recession Continues to Depress Sales at Allied Healthcare Products
2. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
3. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
4. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
5. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
6. HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation
7. University Medical Pharmaceuticals Selects Jeffrey Ten as Senior Vice President, International Sales
8. Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018
9. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
10. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
11. EUCODIS Bioscience Appoints Bhupinder Hundle to Senior Vice President Marketing & Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...  In a sweeping analysis assessing the current state ... researchers conclude that there remains considerable room for ... age groups, but especially for adolescents and young adults. ... treatment, underscoring the need to address barriers to care ... type 1 patients achieve optimal metabolic control. ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... and size the world market for Arthroscopy ... identifies trends impacting the market for these ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3
... THOUSAND OAKS, Calif., Sept. 14 Amgen (Nasdaq: ... Bank of America Merrill Lynch Global Healthcare Conference ... at 9:50 a.m. Greenwich Mean Time.  Amgen executives ... Willard Dere, M.D., senior vice president, International Chief ...
... Sept. 14 Praxis EMR has submitted its application to ... apply for HITECH certification in the country. Under the ARRA ... incentives if they can demonstrate "meaningful use" of a certified ... Department of Health and Human Services to test and certify ...
Cached Medicine Technology:Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference 2Praxis EMR Among First to Apply for HITECH Certification 2
(Date:5/22/2015)... (PRWEB) May 22, 2015 The American ... exciting events in June. They will hold a webinar ... and a two-day class on Classical Chinese Medicine. , ... 3, Dr. Steve Given, the Dean of Clinical Education, ... the new First Professional Doctorate program. ACTCM is currently ...
(Date:5/22/2015)... Hershey, Pa. (PRWEB) May 22, 2015 ... has been selected to participate in the 2015 Congress ... event is described as a gathering of “America’s highest ... about new areas of healthcare, set new goals and ... will include a live surgery, during which we can ...
(Date:5/22/2015)... Carnegie Science Center and ... new partnership to develop BodyTech, a dynamic, three-pronged health ... includes a new exhibit at the Science Center called ... a new traveling science show, Anatomy Adventure, which will ... , Designed to explore a wide range of topics ...
(Date:5/22/2015)... May 22, 2015 Coco Libre, the Official ... RecordSetter.com World Record at the 104th running of the race. ... ice luge served 315 people in one hour—one person about ... race is so true to the heart of the Bay ... an ice luge to the finish line only made sense,” ...
(Date:5/22/2015)... 2015 Medivo, Inc., a leader in lab ... Genotype Results in ‘Baby Boomers’ Screened for HCV Following the ... Test Database” at Digestive Disease Week, May 16-19, 2015. ... Analytics team members Carol Smyth, MB; Jason Bhan, MD; Tatiana ... along with Nancy Reau, MD from the University of Chicago, ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2
... EDITOR,S PICK: VEGF-B helps nerve cells cheat death without unwanted ... VEGF family of proteins, VEGF, has recently been shown to ... However, its clinical utility in this regard is limited, because ... angiogenesis. In a new study, Xuri Li and colleagues at ...
... Provides High-Value Jobs For Commonwealth, HARRISBURG, Pa., ... be better able to put promising Pennsylvania,pharmaceuticals, biotech, ... track for growth, Governor Edward G. Rendell said, ... life sciences industry remains one of the most ...
... Feb. 7 Memory Pharmaceuticals,Corp. (Nasdaq: MEMY ... been,appointed interim President & Chief Executive Officer. In ... largest shareholders, MPM,Capital, Great Point Partners, Oxford Biosciences ... Jim Sulat, who has served as the,Company,s President ...
... HLA-DRB1 increased chances of dying from cardiovascular causes ... gene called HLA-DRB1 that,s associated with an increased ... the chances of premature death from cardiovascular disease ... rheumatoid arthritis (an autoimmune disease) tend to die ...
... What began as a healthy family,recipe for a ... people of all,ages. Triathlete Erin DeMarines, founder of 10-year-old ... 3Bar might have gotten its,start with DeMarines, "friends and ... now available in over 200 retail stores including Publix ...
... the adverse effects of anti-retroviral drugs,shows that two widely-used ... attack/the formation of blood clots in,the heart. With the ... increases by 49%, with Abacavir; the increased risk,is 90%. ... high,underlying cardiovascular risk. The research findings also show,that the ...
Cached Medicine News:Health News:JCI online early table of contents: Feb. 7, 2008 2Health News:JCI online early table of contents: Feb. 7, 2008 3Health News:JCI online early table of contents: Feb. 7, 2008 4Health News:JCI online early table of contents: Feb. 7, 2008 5Health News:JCI online early table of contents: Feb. 7, 2008 6Health News:JCI online early table of contents: Feb. 7, 2008 7Health News:JCI online early table of contents: Feb. 7, 2008 8Health News:Pennsylvania Gov. Rendell: $10 Million Partnership With Harrisburg Venture Capital Firm Boosts PA's Life Sciences Industry 2Health News:Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer 2Health News:Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer 3Health News:Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer 4Health News:Gene Linked to Inflammatory Arthritis Also Raises Heart Risks 2Health News:New Natural Energy Bar Hits the Road with Dieters & Athletes Alike 2Health News:HIV drugs, Abacavir and Didanosine increase the risk of heart attack 2
... Navigaton™ software facilitates real time information ... modules: the first module is a ... devices and the database where information ... module is the user interface, which ...
... The Health Trax System ... (RTLS), long range active RFID, ... in a single intergrated infrastructure. ... valuble assets and people in ...
... Label Gallery is a unique ... software based on an easy-to-use and ... SATO Printers. Label Gallery offers a ... including a multi-lingual user interface and ...
... to protect a wandering resident from leaving ... injured. Such residents typically have been diagnosed ... a head injury., At-risk residents wear a ... ankle, and points of exit are discreetly ...
Medicine Products: